144 related articles for article (PubMed ID: 8615097)
1. Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips.
Gebuhr P; Sletgård J; Dalsgård J; Soelberg M; Keisu K; Hänninen A; Crawford M
Acta Orthop Scand; 1996 Feb; 67(1):29-32. PubMed ID: 8615097
[TBL] [Abstract][Full Text] [Related]
2. Prevention of heterotopic ossification with tenoxicam following total hip arthroplasty: a double-blind, placebo-controlled dose-finding study.
Burssens A; Thiery J; Kohl P; Molderez A; Haazen L
Acta Orthop Belg; 1995; 61(3):205-11. PubMed ID: 8525817
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties.
Kjaersgaard-Andersen P; Nafei A; Teichert G; Kristensen O; Schmidt SA; Keller J; Lucht U
Acta Orthop Scand; 1993 Dec; 64(6):639-42. PubMed ID: 8291408
[TBL] [Abstract][Full Text] [Related]
4. Preoperative irradiation for prevention of heterotopic ossification following total hip arthroplasty.
Pellegrini VD; Gregoritch SJ
J Bone Joint Surg Am; 1996 Jun; 78(6):870-81. PubMed ID: 8666605
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time.
Persson PE; Sodemann B; Nilsson OS
Acta Orthop Scand; 1998 Apr; 69(2):111-5. PubMed ID: 9602764
[TBL] [Abstract][Full Text] [Related]
6. Naproxen in the prevention of heterotopic ossification after total hip replacement.
Vielpeau C; Joubert JM; Hulet C
Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
[TBL] [Abstract][Full Text] [Related]
7. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
Gebuhr PH; Wilbek H; Soelberg M
Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
[TBL] [Abstract][Full Text] [Related]
8. Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients.
Gebuhr P; Soelberg M; Orsnes T; Wilbek H
Acta Orthop Scand; 1991 Jun; 62(3):226-9. PubMed ID: 1904183
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
Nilsson OS
Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
[TBL] [Abstract][Full Text] [Related]
10. Piroxicam versus tenoxicam in spine surgery: a placebo controlled study.
De Decker K; Vercauteren M; Hoffmann V; Lasters B; Adriaensen H
Acta Anaesthesiol Belg; 2001; 52(3):265-9. PubMed ID: 11732382
[TBL] [Abstract][Full Text] [Related]
11. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.
Seegenschmiedt MH; Keilholz L; Martus P; Goldmann A; Wölfel R; Henning F; Sauer R
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):161-71. PubMed ID: 9300751
[TBL] [Abstract][Full Text] [Related]
12. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.
Kölbl O; Knelles D; Barthel T; Raunecker F; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):397-401. PubMed ID: 9788422
[TBL] [Abstract][Full Text] [Related]
13. No effective prophylaxis of heterotopic ossification with short-term ibuprofen.
Koorevaar CT; Hu HP; Lemmens A; van Kampen A
Arch Orthop Trauma Surg; 1999; 119(3-4):183-5. PubMed ID: 10392515
[TBL] [Abstract][Full Text] [Related]
14. Comparative double blind study of the efficacy and safety of tenoxicam vs. piroxicam in osteoarthritis of knee and hip joints.
Adelowo OO; Chukwuani CM; Grange JJ; Ojeasebhulo EE; Onabowale BO
West Afr J Med; 1998; 17(3):194-8. PubMed ID: 9814091
[TBL] [Abstract][Full Text] [Related]
15. Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty.
Sodemann B; Persson PE; Nilsson OS
Clin Orthop Relat Res; 1988 Dec; (237):158-63. PubMed ID: 3142716
[TBL] [Abstract][Full Text] [Related]
16. A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
Bird HA; Hill J; Dixon JS; Looi D; Wright V
Eur J Rheumatol Inflamm; 1985; 8(1):53-9. PubMed ID: 3915888
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial.
Nayak KN; Mulliken B; Rorabeck CH; Bourne RB; Woolfrey MR
Can J Surg; 1997 Oct; 40(5):368-74. PubMed ID: 9336527
[TBL] [Abstract][Full Text] [Related]
18. Heterotopic ossification after primary cemented and noncemented total hip arthroplasty in patients with osteoarthritis and rheumatoid arthritis.
Lieberman IH; Moran E; Hastings DE; Bogoch ER
Can J Surg; 1994 Apr; 37(2):135-9. PubMed ID: 8156466
[TBL] [Abstract][Full Text] [Related]
19. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
Kjaersgaard-Andersen P; Schmidt SA
Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
[TBL] [Abstract][Full Text] [Related]
20. Hip Arthroscopy and Heterotopic Ossification: Is NSAID Prophylaxis Justified? Commentary on an article by James T. Beckmann, MD, MS, et al.: "Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial".
Løken S
J Bone Joint Surg Am; 2015 Dec; 97(24):e80. PubMed ID: 26677244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
